Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,deferredLongTermAssetCharges,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,netReceivables,longTermDebt,inventory,accountsPayable,otherCurrentAssets,investments,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,otherCashflowsFromInvestingActivities,dividendsPaid,changeToInventory,changeToAccountReceivables,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,currency,market,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,shortName,exchange,marketState,twoHundredDayAverageChangePercent,exchangeDataDelayedBy,esgPopulated,tradeable,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,trailingAnnualDividendRate,trailingPE,trailingAnnualDividendYield,epsTrailingTwelveMonths,priceHint,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,compensationRisk,auditRisk,longBusinessSummary,city,phone,shareHolderRightsRisk,compensationAsOfEpochDate,governanceEpochDate,boardRisk,country,website,maxAge,overallRisk,address1,fax,industry
t0,ERFSF,-658900000.0,191212000,,,271850000,26100000,222350000,300000,459600000,326500000,326500000,,-26850000,,,,48950000,1557700000,1231200000,1098100000,-54650000,,222900000,213800000,825100000.0,4859100000.0,3690300000.0,397600000.0,8575500000.0,1900000.0,1310500000.0,245500000.0,3524100000.0,2377900000.0,119100000.0,912400000.0,1696400000.0,76600000.0,101800000.0,2377900000.0,1574900000.0,2518200000.0,14100000.0,1389100000.0,2502400000.0,157000000.0,278800000.0,,200000,73150000,-159850000,-52400000,-66600000,32300000,10100000,148450000,-14300000,389250000,146100000,700000,-10850000,-38850000,-96150000,-13450000,48300000,-98900000,821800000.0,en-US,US,EQUITY,False,Delayed Quote,USD,us_market,140.75,1630508711,-2.350006,140.75,140.75,140.75,1,EUROFINS SCIENTIFIC SE,PNK,REGULAR,0.2945185,0,False,False,-1.6422125,140.75 - 140.75,143.1,0.0,0.0,0,0,finmb_883811,Other OTC,Eurofins Scientific SE,EUR,660,150,69.24,0.9682561,71.51 - 147.25,-6.5,-0.044142615,71.51,147.25,0.68,45.69805,0.0047519216,3.08,2,19.342,130.24278,10.507217,0.08067408,108.727684,32.022316,27437103104,7.276911,15,America/New_York,EDT,-14400000,0.57,,,147.25,71.51,130.24,108.73,660,150,191.21M,,127.23M,33.65%,33.48%,,,,,,0.81,0.72%,0.68,0.48%,,0.00%,,"Jun 30, 2021",10:1,"Nov 18, 2020","Dec 30, 2020","Dec 30, 2020",9.92%,16.63%,6.89%,16.34%,5.44B,29.21,30.10%,1.41B,1.27B,505.3M,3.08,226.30%,912.5M,4.78,3.15B,84.89,1.48,19.34,1.22B,793.08M,Value,1526,Healthcare,51516,10,8,"Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 200,000 analytical methods for evaluating the safety, identity, composition, authenticity, origin, traceability, and purity of biological substances and products, as well as for clinical diagnostic. It provides agroscience, agro testing, assurance, biopharma, clinical diagnostics, consumer product testing, cosmetics and personal care, environment testing, food and feed testing, forensic, genomic, maritime, materials and engineering, technologies, and REACH services. The company serves clients from a range of industries, including the pharmaceutical, food, environmental, and clinical diagnostics sectors. It operates approximately 800 laboratories in 50 countries. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.",Luxembourg City,352 26 18 53 20,9,1609372800,1622505600,3,Luxembourg,http://www.eurofins.com,86400,8,23 Val Fleuri,352 26 18 53 31,Diagnostics & Research
t-1,ERFSF,-658900000.0,191212000,,,271850000,26100000,222350000,300000,459600000,326500000,326500000,,-26850000,,,,48950000,1557700000,1231200000,1098100000,-54650000,,222900000,213800000,825100000.0,4859100000.0,3690300000.0,397600000.0,8575500000.0,1900000.0,1310500000.0,245500000.0,3524100000.0,2377900000.0,119100000.0,912400000.0,1696400000.0,76600000.0,101800000.0,2377900000.0,1574900000.0,2518200000.0,14100000.0,1389100000.0,2502400000.0,157000000.0,278800000.0,,200000,73150000,-159850000,-52400000,-66600000,32300000,10100000,148450000,-14300000,389250000,146100000,700000,-10850000,-38850000,-96150000,-13450000,48300000,-98900000,821800000.0,en-US,US,EQUITY,False,Delayed Quote,USD,us_market,140.75,1630508711,-2.350006,140.75,140.75,140.75,1,EUROFINS SCIENTIFIC SE,PNK,REGULAR,0.2945185,0,False,False,-1.6422125,140.75 - 140.75,143.1,0.0,0.0,0,0,finmb_883811,Other OTC,Eurofins Scientific SE,EUR,660,150,69.24,0.9682561,71.51 - 147.25,-6.5,-0.044142615,71.51,147.25,0.68,45.69805,0.0047519216,3.08,2,19.342,130.24278,10.507217,0.08067408,108.727684,32.022316,27437103104,7.276911,15,America/New_York,EDT,-14400000,0.57,,,147.25,71.51,130.24,108.73,660,150,191.21M,,127.23M,33.65%,33.48%,,,,,,0.81,0.72%,0.68,0.48%,,0.00%,,"Jun 30, 2021",10:1,"Nov 18, 2020","Dec 30, 2020","Dec 30, 2020",9.92%,16.63%,6.89%,16.34%,5.44B,29.21,30.10%,1.41B,1.27B,505.3M,3.08,226.30%,912.5M,4.78,3.15B,84.89,1.48,19.34,1.22B,793.08M,Value,1526,Healthcare,51516,10,8,"Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 200,000 analytical methods for evaluating the safety, identity, composition, authenticity, origin, traceability, and purity of biological substances and products, as well as for clinical diagnostic. It provides agroscience, agro testing, assurance, biopharma, clinical diagnostics, consumer product testing, cosmetics and personal care, environment testing, food and feed testing, forensic, genomic, maritime, materials and engineering, technologies, and REACH services. The company serves clients from a range of industries, including the pharmaceutical, food, environmental, and clinical diagnostics sectors. It operates approximately 800 laboratories in 50 countries. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.",Luxembourg City,352 26 18 53 20,9,1609372800,1622505600,3,Luxembourg,http://www.eurofins.com,86400,8,23 Val Fleuri,352 26 18 53 31,Diagnostics & Research
t-2,ERFSF,-1052600000.0,191212000,,,75300000,47600000,47350000,300000,246750000,125700000,125700000,,-25500000,,,,28000000,1161700000,1036000000,914950000,-50400000,,47300000,38850000,880000000.0,4612000000.0,3428400000.0,762300000.0,8088000000.0,1900000.0,821400000.0,261300000.0,3601000000.0,2605100000.0,51800000.0,615400000.0,1418700000.0,51900000.0,130600000.0,2605100000.0,1567500000.0,1935700000.0,52000000.0,1019300000.0,2379400000.0,123900000.0,389000000.0,200000.0,-250000,0,-102650000,-202050000,42300000,5350000,272150000,159550000,-2650000,222500000,99850000,600000,-7300000,-38850000,-96150000,-20500000,69950000,-56500000,517000000.0,en-US,US,EQUITY,False,Delayed Quote,USD,us_market,140.75,1630508711,-2.350006,140.75,140.75,140.75,1,EUROFINS SCIENTIFIC SE,PNK,REGULAR,0.2945185,0,False,False,-1.6422125,140.75 - 140.75,143.1,0.0,0.0,0,0,finmb_883811,Other OTC,Eurofins Scientific SE,EUR,660,150,69.24,0.9682561,71.51 - 147.25,-6.5,-0.044142615,71.51,147.25,0.68,45.69805,0.0047519216,3.08,2,19.342,130.24278,10.507217,0.08067408,108.727684,32.022316,27437103104,7.276911,15,America/New_York,EDT,-14400000,0.57,,,147.25,71.51,130.24,108.73,660,150,191.21M,,127.23M,33.65%,33.48%,,,,,,0.81,0.72%,0.68,0.48%,,0.00%,,"Jun 30, 2021",10:1,"Nov 18, 2020","Dec 30, 2020","Dec 30, 2020",9.92%,16.63%,6.89%,16.34%,5.44B,29.21,30.10%,1.41B,1.27B,505.3M,3.08,226.30%,912.5M,4.78,3.15B,84.89,1.48,19.34,1.22B,793.08M,Value,1526,Healthcare,51516,10,8,"Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 200,000 analytical methods for evaluating the safety, identity, composition, authenticity, origin, traceability, and purity of biological substances and products, as well as for clinical diagnostic. It provides agroscience, agro testing, assurance, biopharma, clinical diagnostics, consumer product testing, cosmetics and personal care, environment testing, food and feed testing, forensic, genomic, maritime, materials and engineering, technologies, and REACH services. The company serves clients from a range of industries, including the pharmaceutical, food, environmental, and clinical diagnostics sectors. It operates approximately 800 laboratories in 50 countries. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.",Luxembourg City,352 26 18 53 20,9,1609372800,1622505600,3,Luxembourg,http://www.eurofins.com,86400,8,23 Val Fleuri,352 26 18 53 31,Diagnostics & Research
t-3,ERFSF,-1052600000.0,191212000,,,75300000,47600000,47350000,300000,246750000,125700000,125700000,,-25500000,,,,28000000,1161700000,1036000000,914950000,-50400000,,47300000,38850000,880000000.0,4612000000.0,3428400000.0,762300000.0,8088000000.0,1900000.0,821400000.0,261300000.0,3601000000.0,2605100000.0,51800000.0,615400000.0,1418700000.0,51900000.0,130600000.0,2605100000.0,1567500000.0,1935700000.0,52000000.0,1019300000.0,2379400000.0,123900000.0,389000000.0,200000.0,-250000,0,-102650000,-202050000,42300000,5350000,272150000,159550000,-2650000,222500000,99850000,600000,-7300000,-38850000,-96150000,-20500000,69950000,-56500000,517000000.0,en-US,US,EQUITY,False,Delayed Quote,USD,us_market,140.75,1630508711,-2.350006,140.75,140.75,140.75,1,EUROFINS SCIENTIFIC SE,PNK,REGULAR,0.2945185,0,False,False,-1.6422125,140.75 - 140.75,143.1,0.0,0.0,0,0,finmb_883811,Other OTC,Eurofins Scientific SE,EUR,660,150,69.24,0.9682561,71.51 - 147.25,-6.5,-0.044142615,71.51,147.25,0.68,45.69805,0.0047519216,3.08,2,19.342,130.24278,10.507217,0.08067408,108.727684,32.022316,27437103104,7.276911,15,America/New_York,EDT,-14400000,0.57,,,147.25,71.51,130.24,108.73,660,150,191.21M,,127.23M,33.65%,33.48%,,,,,,0.81,0.72%,0.68,0.48%,,0.00%,,"Jun 30, 2021",10:1,"Nov 18, 2020","Dec 30, 2020","Dec 30, 2020",9.92%,16.63%,6.89%,16.34%,5.44B,29.21,30.10%,1.41B,1.27B,505.3M,3.08,226.30%,912.5M,4.78,3.15B,84.89,1.48,19.34,1.22B,793.08M,Value,1526,Healthcare,51516,10,8,"Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 200,000 analytical methods for evaluating the safety, identity, composition, authenticity, origin, traceability, and purity of biological substances and products, as well as for clinical diagnostic. It provides agroscience, agro testing, assurance, biopharma, clinical diagnostics, consumer product testing, cosmetics and personal care, environment testing, food and feed testing, forensic, genomic, maritime, materials and engineering, technologies, and REACH services. The company serves clients from a range of industries, including the pharmaceutical, food, environmental, and clinical diagnostics sectors. It operates approximately 800 laboratories in 50 countries. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.",Luxembourg City,352 26 18 53 20,9,1609372800,1622505600,3,Luxembourg,http://www.eurofins.com,86400,8,23 Val Fleuri,352 26 18 53 31,Diagnostics & Research
